New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
16:24 EDTORCL, HEB, RGR, NLSN, SWHC, GTAT, ARBOn The Fly: Closing Wrap
Stocks on Wall Street were higher, with the buying spurred on by optimism surrounding the fiscal cliff negotiations. After surging higher during the first half of the trading session, the averages moved in a narrow range through the afternoon, though held onto gains and closed right near their highs... ECONOMIC EVENTS: In the U.S., the National Association of Home Builders index of builder confidence increased to 47, as was forecast. Also, the current-account deficit in the U.S. narrowed in the third quarter to $107.5B from a $118.1B shortfall in the prior quarter. Economists expected the deficit would narrow to about $103B... COMPANY NEWS: After the bell, Oracle (ORCL) reported earnings and revenues that beat Street expectations. Shares, which had been up 1.67% during the trading session, moved up another 1.5% in after hours trading following the report... Gunmakers Smith & Wesson (SWHC) and Sturm, Ruger (RGR) continued their recent weakness as private equity firm Cerberus Capital Management's decision to put gunmaker Freedom Group up for sale added new pressure on those stocks. Shares of Smith & Wesson lost 86c, or 9.99%, to close at $7.79, while shares of Sturm, Ruger fell $3.40, or 7.73%, to close at $40.60... MAJOR MOVERS: Among the notable gainers was Arbitron (ARB), up $8.99, or 23.63%, to $47.03 after agreeing to be bought by Nielsen (NLSN) for $48 per share in cash. Shares of acquirer Nielsen also gained $1.30, or 4.39%, to $30.92. Among the noteworthy losers was GT Advanced Technologies (GTAT), which was downgraded at Raymond James and Stifel Nicolaus and saw shares fall 39c, or 11.27%, to $3.07 after issuing guidance well below consensus. Also lower was Hemispherex Biopharma (HEB), down 27.6c, or 42.86%, to 36.8c, after the FDA posted documents in advance of a review of the company's Ampligen drug, noting that the agency had concerns with the drug's efficacy and safety data... INDICES: The Dow was up 115.57, or 0.87%, to 13,350.96; the Nasdaq was up 43.93, or 1.46%, to 3,054.53; and the S&P 500 was up 16.43, or 1.15%, to 1,446.79.
News For ORCL;SWHC;RGR;ARB;NLSN;HEB;GTAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 7, 2015
07:06 EDTORCLAccenture chosen by San Francisco for financial management system
Subscribe for More Information
05:26 EDTORCLOracle implied volatility of 20 at lower end of index mean range
Subscribe for More Information
October 6, 2015
07:17 EDTORCLStrategic News Service to hold a conference
Subscribe for More Information
October 5, 2015
17:30 EDTSWHC, RGRGunmakers surge as Clinton vows regulatory reform
Shares of gunmakers Smith & Wesson (SWHC) and Sturm Ruger (RGR) advanced Monday after presidential candidate Hillary Clinton reaffirmed her vow to expand firearm regulations following last week's Oregon shooting. REGULATORY PROMISES: Speaking at a New Hampshire town hall meeting, Hillary Clinton outlined her plan to reduce gun violence across the United States. The presidential candidate vowed to close loopholes affecting sales at gun shows and over the Internet, no longer permitting private sellers to skip background checks. Additionally, the Democrat promised to revise the so-called "default proceed" rule, which currently allows gun sales to proceed without background checks if that check is not completed within three days. Clinton also said she would strive to repeal a law preventing victims of gun crime from suing the firearm manufacturers themselves, and called for comprehensive background checks to "keep guns out of the hands of domestic abusers, other violent criminals, and the severely mentally ill." PRICE ACTION: Shares of Smith & Wesson and Sturm Ruger rose a respective 7.29% and 2.75% during Monday's session, while hunting retailer Cabelas (CAB) advanced 2.88%. The positive moves come after a reported surge in gun sales on fears of sharply increased regulations, with Clinton notably promising to "take administrative action" on the issue.
September 30, 2015
13:39 EDTNLSNAnalysts, investors cheer Rentrak, comScore merger plan
Shares of both Rentrak (RENT) and comScore (SCOR) are driving higher in afternoon trading after the companies announced a stock-for-stock merger agreement following Tuesday's session close. The move could see the companies developing new, compelling products to track cross-platform media consumption amid changing viewership trends, according to executives and analysts. MERGER: Rentrak and comScore announced a stock-for-stock merger agreement that will see comScore shareholders owning approximately 66.5% of the combined company and Rentrak shareholders owning roughly 33.5%. comScore's current CEO, Serge Matta, will lead the combined company as Chief Executive, while Rentrak CEO Bill Livek will transition to executive vice chairman and president. The combined company expects total synergies of at least $20M in 2016 and at least $35M in 2017, with those figures "very, very heavily" weighted towards revenue, as noted by comScore CFO Mel Wesley. EXECUTIVE COMMENTARY: On a conference call discussing the merger agreement, comScore Chief Executive Matta remarked that the media industry is at an "inflection point" in terms of consumer behavior, which is trending towards cross-platform, cross-device, delayed media viewing. Rentrak Chief Bill Livek explained that the combined company will be capable of delivering cross-platform viewership and advertising metrics "that account for all of the ways in which content is consumed," something that the industry has been "pleading" for, according to Livek. ANALYST TAKE: William Blair analyst Timothy McHugh weighed in on the merger, saying that while both companies previously had some fledgling cross-platform initiatives, their combined capability is undoubtedly stronger. McHugh added that the industry "ultimately appears headed" towards cross-media consumption habits, to which the combined company should be better positioned to respond. On the other hand, Rentrak-comScore still cannot truly challenge Nielsen's (NLSN) TV metrics even as the company develops similar cross-platform capabilities, said McHugh, though he did acknowledge that the deal looks incrementally negative for Nielsen. Meanwhile, Needham analyst Laura Martin said the "compelling" deal still relies on the merged company's eventual cross-platform products, which must be seen as unknowns at this point. Martin downgraded Rentrak to Buy from Strong Buy and cut her price target to $60 from $85, noting that if the deal fails, she believes there are other potential purchasers for Rentrak. PRICE ACTION: Shares of Rentrak are up about 24% to roughly $54 in Wednesday afternoon trading, while comScore has risen about 12% to trade above $46 per share. Meanwhile, Nielsen has slipped about 2.5% to $44 per share.
08:09 EDTNLSNMobee announces collaboration with Nielsen
07:14 EDTNLSNcomScore, Rentrak merger makes lot of strategic sense, says William Blair
Subscribe for More Information
06:58 EDTORCLOracle to furlough workers during holiday week, BI reports
Oracle has decided to close down during the holiday week between Christmas and New Year's, mandating that its employees pay for this furlough with paid vacation time, Business Insider reports, citing several sources. Some Oracle employees have been angered about this move that basically removes four days of paid time off from them, the report says. Reference Link
September 29, 2015
08:39 EDTORCLOracle Health Sciences adds 93 biopharma customers
Oracle (ORCL) Health Sciences announced that 93 emerging biopharma organizations worldwide have become new customers in the past year, adopting Oracle Health Sciences solutions to succeed in this rapidly evolving market and deliver drugs to patients faster. Organizations, including Accera and NewLink (NLNK), selected Oracle Health Sciences solutions to manage their end-to-end clinical trial processes, boost clinical development productivity, facilitate compliance, and build scalable, affordable platforms for growth.
September 28, 2015
08:35 EDTHEBHemispherx Biopharma wins EPO grant of new composition patent for Ampligen
Subscribe for More Information
September 23, 2015
10:20 EDTORCLOptions with decreasing implied volatility
Options with decreasing implied volatility: CVC HRTX NWBO ATML RHT KMX OVTI ADBE ORCL DRI

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use